Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration

被引：24

作者：

Markowitz, JS ^{[1
]}

DeVane, CL ^{[1
]}

机构：

[1] Med Univ S Carolina, Inst Psychiat, Charleston, SC 29425 USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 03期

关键词：

D O I：

10.1097/00004714-199906000-00023

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：289 / 291

页数：3

共 19 条

[1]

*BAY CORP, 1998, CIPR PROD INF

[2] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].

Beasley, CM ;

Tollefson, G ;

Tran, P ;

Satterlee, W ;

Sanger, T ;

Hamilton, S ;

Fabre, L ;

Small, J ;

Ereshefsky, L ;

True, J ;

Nemeroff, C ;

Risch, SC ;

Perry, PJ ;

Potkin, SG ;

Borison, RL ;

James, S ;

Meltzer, HY ;

Iqbal, N ;

Fann, WE ;

Gewirtz, GR ;

Landbloom, R ;

RoyByrne, PP ;

Tuason, VB ;

Carman, JS ;

Stokes, PE ;

Williams, R ;

Ancill, RJ ;

MacEwan, GW ;

Gujavarty, KS ;

Jones, B ;

Lohr, JB .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123

[3]

DEVANE CL, 1997, AM PSYCH ASS ANN M S

[4]

*E LILL IND INC, 1998, ZYPR PROD INF

[5]

Edge SC, 1997, HUM PSYCHOPHARM CLIN, V12, P5, DOI 10.1002/(SICI)1099-1077(199701/02)12:1<5::AID-HUP831>3.0.CO

[6]

2-4

[7] INHIBITORY POTENCY OF QUINOLONE ANTIBACTERIAL AGENTS AGAINST CYTOCHROME-P450IA2 ACTIVITY INVIVO AND INVITRO [J].

FUHR, U ;

ANDERS, EM ;

MAHR, G ;

SORGEL, F ;

STAIB, AH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :942-948

[8] Clinical pharmacokinetics of nefazodone [J].

Greene, DS ;

Barbhaiya, RH .

CLINICAL PHARMACOKINETICS, 1997, 33 (04) :260-275

[9] FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J].

JERLING, M ;

LINDSTROM, L ;

BONDESSON, U ;

BERTILSSON, L .

THERAPEUTIC DRUG MONITORING, 1994, 16 (04) :368-374

[10]

Kassahun K, 1997, DRUG METAB DISPOS, V25, P81

← 1 2 →